Acute myeloid leukemia evolving from essential thrombocythemia in two patients treated with hydroxyurea (Q70944902)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579054%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Acute myeloid leukemia evolving from essential thrombocythemia in two patients treated with hydroxyurea (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579054%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

main subject

acute myeloid leukemia

1 reference

1 reference

Furgerson JL

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579054%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Vukelja SJ

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579054%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Baker WJ

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579054%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

O'Rourke TJ

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579054%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

publication date

1 February 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579054%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Hematology

15 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579054%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579054%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579054%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

137-140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579054%20AND%20SRC:MED&resulttype=core&format=json

Essential thrombocythemias. Clinical evolutionary and biological data

15 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199602%2951%3A2%3C137%3A%3AAID-AJH7%3E3.0.CO%3B2-Z

Acute leukemia as a natural sequel to primary thrombocythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199602%2951%3A2%3C137%3A%3AAID-AJH7%3E3.0.CO%3B2-Z

The chromosomal basis of human neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199602%2951%3A2%3C137%3A%3AAID-AJH7%3E3.0.CO%3B2-Z

Cytogenetic abnormalities and leukemic transformation in hydroxyurea-treated patients with Philadelphia chromosome negative chronic myeloproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199602%2951%3A2%3C137%3A%3AAID-AJH7%3E3.0.CO%3B2-Z

Myelodysplastic syndrome and secondary acute leukemia after treatment of essential thrombocythemia with hydroxyurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199602%2951%3A2%3C137%3A%3AAID-AJH7%3E3.0.CO%3B2-Z

Megakaryoblastic transformation of primary thrombocythemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199602%2951%3A2%3C137%3A%3AAID-AJH7%3E3.0.CO%3B2-Z

Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: prospective study of efficacy and leukaemogenicity with therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199602%2951%3A2%3C137%3A%3AAID-AJH7%3E3.0.CO%3B2-Z

Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199602%2951%3A2%3C137%3A%3AAID-AJH7%3E3.0.CO%3B2-Z

Essential thrombocythemia. Clinical characteristics and course of 61 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199602%2951%3A2%3C137%3A%3AAID-AJH7%3E3.0.CO%3B2-Z

Anagrelide: A New Drug for Treating Thrombocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199602%2951%3A2%3C137%3A%3AAID-AJH7%3E3.0.CO%3B2-Z

Augmentation by Erythropoietin of the Fetal-Hemoglobin Response to Hydroxyurea in Sickle Cell Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199602%2951%3A2%3C137%3A%3AAID-AJH7%3E3.0.CO%3B2-Z

10.1002/(SICI)1096-8652(199602)51:2<137::AID-AJH7>3.0.CO;2-Z

21 January 2018

Identifiers

DOI

0 references

1 reference